102 related articles for article (PubMed ID: 1544456)
1. High-affinity binding sites for 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12(S)-HETE) in carcinoma cells.
Herbertsson H; Hammarström S
FEBS Lett; 1992 Feb; 298(2-3):249-52. PubMed ID: 1544456
[TBL] [Abstract][Full Text] [Related]
2. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction.
Honn KV; Tang DG; Grossi I; Duniec ZM; Timar J; Renaud C; Leithauser M; Blair I; Johnson CR; Diglio CA
Cancer Res; 1994 Jan; 54(2):565-74. PubMed ID: 8275495
[TBL] [Abstract][Full Text] [Related]
3. Langerhans cells of the human skin possess high-affinity 12(S)-hydroxyeicosa tetraenoic acid receptors.
Arenberger P; Kemény L; Rupec R; Bieber T; Ruzicka T
Eur J Immunol; 1992 Sep; 22(9):2469-72. PubMed ID: 1325349
[TBL] [Abstract][Full Text] [Related]
4. High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line.
Gross E; Ruzicka T; von Restorff B; Stolz W; Klotz KN
J Invest Dermatol; 1990 Apr; 94(4):446-51. PubMed ID: 2313116
[TBL] [Abstract][Full Text] [Related]
5. Characterization of high-affinity 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding sites on normal human keratinocytes.
Arenberger P; Kemény L; Ruzicka T
Epithelial Cell Biol; 1993 Jan; 2(1):1-6. PubMed ID: 8394769
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid binding sites in Lewis lung carcinoma cells.
Herbertsson H; Hammarström S
Biochim Biophys Acta; 1995 May; 1244(1):191-7. PubMed ID: 7766658
[TBL] [Abstract][Full Text] [Related]
7. Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid.
Grossi IM; Fitzgerald LA; Umbarger LA; Nelson KK; Diglio CA; Taylor JD; Honn KV
Cancer Res; 1989 Feb; 49(4):1029-37. PubMed ID: 2492204
[TBL] [Abstract][Full Text] [Related]
8. Evidence for LTB4/12-HETE binding sites in a human epidermal cell line.
Gross E; Ruzicka T; Mauch C; Krieg T
Prostaglandins; 1988 Jul; 36(1):49-58. PubMed ID: 2845483
[TBL] [Abstract][Full Text] [Related]
9. Characterization of specific subcellular 15-hydroxyeicosatetraenoic acid (15-HETE) binding sites on rat basophilic leukemia cells.
Kang LT; Vanderhoek JY
Biochim Biophys Acta; 1995 Jun; 1256(3):297-304. PubMed ID: 7786891
[TBL] [Abstract][Full Text] [Related]
10. Evidence for specific binding of 15 hydroxyeicosatetraenoic acid to pituitary rat cells.
Rabier M; Crastes de Paulet A; Damon M
Biochem Biophys Res Commun; 1988 May; 152(3):1179-84. PubMed ID: 2837180
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid binding sites in carcinoma cells.
Herbertsson H; Hammarström S
Adv Exp Med Biol; 1997; 400A():287-93. PubMed ID: 9547570
[TBL] [Abstract][Full Text] [Related]
12. The lipoxygenase inhibitor 2-phenylmethyl-1-naphthol (DuP 654) is a 12(S)-hydroxyeicosatetraenoic acid receptor antagonist in the human epidermal cell line SCL-II.
Arenberger P; Raap A; Armah B; Kemény L; Ruzicka T
Skin Pharmacol; 1993; 6(2):148-51. PubMed ID: 8394724
[TBL] [Abstract][Full Text] [Related]
13. 12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids.
Liu B; Khan WA; Hannun YA; Timar J; Taylor JD; Lundy S; Butovich I; Honn KV
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9323-7. PubMed ID: 7568126
[TBL] [Abstract][Full Text] [Related]
14. The 650-kDa 12(S)-hydroxyeicosatetraenoic acid binding complex: occurrence in human platelets, identification of hsp90 as a constituent, and binding properties of its 50-kDa subunit.
Herbertsson H; Kühme T; Hammarström S
Arch Biochem Biophys; 1999 Jul; 367(1):33-8. PubMed ID: 10375396
[TBL] [Abstract][Full Text] [Related]
15. The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells.
Chopra H; Timar J; Chen YQ; Rong XH; Grossi IM; Fitzgerald LA; Taylor JD; Honn KV
Int J Cancer; 1991 Nov; 49(5):774-86. PubMed ID: 1937964
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid and other hydroxylated fatty acids by the reductase pathway in porcine polymorphonuclear leukocytes.
Wainwright S; Falck JR; Yadagiri P; Powell WS
Biochemistry; 1990 Oct; 29(43):10126-35. PubMed ID: 2176862
[TBL] [Abstract][Full Text] [Related]
17. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
Tang DG; Diglio CA; Honn KV
Cancer Res; 1994 Feb; 54(4):1119-29. PubMed ID: 8313370
[TBL] [Abstract][Full Text] [Related]
18. Effect of ciclosporin on epidermal 12(S)-hydroxyeicosatetraenoic acid binding sites.
Arenberger P; Ruzicka T; Kemény L
Skin Pharmacol; 1991; 4(4):272-7. PubMed ID: 1789988
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential.
Liu B; Marnett LJ; Chaudhary A; Ji C; Blair IA; Johnson CR; Diglio CA; Honn KV
Lab Invest; 1994 Mar; 70(3):314-23. PubMed ID: 8145526
[TBL] [Abstract][Full Text] [Related]
20. Regulation of endothelial cell and platelet receptor-ligand binding by the 12- and 15-lipoxygenase monohydroxides, 12-, 15-HETE and 13-HODE.
Buchanan MR; Horsewood P; Brister SJ
Prostaglandins Leukot Essent Fatty Acids; 1998 May; 58(5):339-46. PubMed ID: 9690711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
